Gossamer Bio GOSS Stock
Gossamer Bio Price Chart
Gossamer Bio GOSS Financial and Trading Overview
Gossamer Bio stock price | 1.12 USD |
Previous Close | 1.25 USD |
Open | 1.29 USD |
Bid | 0 USD x 2200 |
Ask | 0 USD x 3200 |
Day's Range | 1.2 - 1.53 USD |
52 Week Range | 0.91 - 15.2 USD |
Volume | 5.85M USD |
Avg. Volume | 2.87M USD |
Market Cap | 130.76M USD |
Beta (5Y Monthly) | 1.198755 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.25 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 6.45 USD |
GOSS Valuation Measures
Enterprise Value | 151.29M USD |
Trailing P/E | N/A |
Forward P/E | -0.958042 |
PEG Ratio (5 yr expected) | -0.13 |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | N/A |
Enterprise Value/EBITDA | -0.719 |
Trading Information
Gossamer Bio Stock Price History
Beta (5Y Monthly) | 1.198755 |
52-Week Change | -79.52% |
S&P500 52-Week Change | 20.43% |
52 Week High | 15.2 USD |
52 Week Low | 0.91 USD |
50-Day Moving Average | 1.24 USD |
200-Day Moving Average | 5.05 USD |
GOSS Share Statistics
Avg. Volume (3 month) | 2.87M USD |
Avg. Daily Volume (10-Days) | 2.8M USD |
Shares Outstanding | 95.44M |
Float | 79.18M |
Short Ratio | 8.99 |
% Held by Insiders | 4.74% |
% Held by Institutions | 118.76% |
Shares Short | 15.26M |
Short % of Float | 24.66% |
Short % of Shares Outstanding | 15.98% |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | 0% |
Gross Margin | 0% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -51.53% |
Return on Equity (ttm) | -25925.77% |
Income Statement
Revenue (ttm) | N/A |
Revenue Per Share (ttm) | N/A |
Quarterly Revenue Growth (yoy) | N/A |
Gross Profit (ttm) | N/A |
EBITDA | -210287008 USD |
Net Income Avi to Common (ttm) | -220758000 USD |
Diluted EPS (ttm) | -2.9 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 201.86M USD |
Total Cash Per Share (mrq) | 2.12 USD |
Total Debt (mrq) | 222.46M USD |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | 5.186 |
Book Value Per Share (mrq) | -0.298 |
Cash Flow Statement
Operating Cash Flow (ttm) | -186538000 USD |
Levered Free Cash Flow (ttm) | -101514128 USD |
Profile of Gossamer Bio
Country | United States |
State | CA |
City | San Diego |
Address | 3013 Science Park Road |
ZIP | 92121 |
Phone | 858 684 1300 |
Website | https://www.gossamerbio.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | 178 |
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colonystimulating factor 1 receptor, or CSF1R, and c-KIT inhibitor for the treatment of pulmonary arterial hypertension; GB004, a gut-targeted, oral small molecule for the treatment of inflammatory bowel disease; GB5121, an oral, irreversible, covalent, small molecule inhibitor of Bruton's Tyrosine Kinase for the treatment of primary central nervous system lymphoma; and GB7208, an oral, small molecule, BTK inhibitor for the treatment of multiple sclerosis. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds; and Aerpio Pharmaceuticals, Inc. to develop and commercialize GB004 and related compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. Gossamer Bio, Inc. was incorporated in 2015 and is headquartered in San Diego, California.
Q&A For Gossamer Bio Stock
What is a current GOSS stock price?
Gossamer Bio GOSS stock price today per share is 1.12 USD.
How to purchase Gossamer Bio stock?
You can buy GOSS shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Gossamer Bio?
The stock symbol or ticker of Gossamer Bio is GOSS.
Which industry does the Gossamer Bio company belong to?
The Gossamer Bio industry is Biotechnology.
How many shares does Gossamer Bio have in circulation?
The max supply of Gossamer Bio shares is 227.22M.
What is Gossamer Bio Price to Earnings Ratio (PE Ratio)?
Gossamer Bio PE Ratio is now.
What was Gossamer Bio earnings per share over the trailing 12 months (TTM)?
Gossamer Bio EPS is -0.25 USD over the trailing 12 months.
Which sector does the Gossamer Bio company belong to?
The Gossamer Bio sector is Healthcare.
Gossamer Bio GOSS included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
NASDAQ Composite IXIC | 17928.92 USD — |
<0.01
|
8.13B USD — | 17853.84 USD — | 18068.9 USD — | — - | 8.13B USD — |
NASDAQ Global Select Market Com NQGS | 8770.07 USD — |
+1.03
|
— — | 8697.51 USD — | 8852.92 USD — | — - | — — |
NASDAQ Biotechnology NBI | 3985.14 USD — |
-0.23
|
— — | 3895.36 USD — | 4020.49 USD — | — - | — — |
NASDAQ HealthCare IXHC | 914.07 USD — |
+0.22
|
— — | 901.03 USD — | 922.51 USD — | — - | — — |
Stlmt ID NASDAQ Biotechnology NBX | 3959.31 USD — |
-0.92
|
— — | 3927.42 USD — | 4274.23 USD — | — - | — — |
- {{ link.label }} {{link}}